BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 29138577)

  • 1. Identification and validation of potential prognostic gene biomarkers for predicting survival in patients with acute myeloid leukemia.
    Huang R; Liao X; Li Q
    Onco Targets Ther; 2017; 10():5243-5254. PubMed ID: 29138577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Metabolism-Related Gene Signature Predicts the Survival of Patients with Acute Myeloid Leukemia.
    Zhai Y; Shen H; Wei H
    Genes (Basel); 2023 Dec; 15(1):. PubMed ID: 38254953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. m6A genotypes and prognostic signature for assessing the prognosis of patients with acute myeloid leukemia.
    Fu C; Kou R; Meng J; Jiang D; Zhong R; Dong M
    BMC Med Genomics; 2023 Aug; 16(1):191. PubMed ID: 37596597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel 5-gene prognostic signature to improve risk stratification of cytogenetically normal acute myeloid leukemia.
    Deng C; Zeng T; Zhu P; Zhao S; Huang Z; Huang W; Zhang W; Huang X; Fu L
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10015-10025. PubMed ID: 37258721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification and validation of signal recognition particle 14 as a prognostic biomarker predicting overall survival in patients with acute myeloid leukemia.
    Shi L; Huang R; Lai Y
    BMC Med Genomics; 2021 May; 14(1):127. PubMed ID: 33985510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and Validation of a Prognostic Risk-Scoring Model Based on Ferroptosis-Associated Cluster in Acute Myeloid Leukemia.
    Wang J; Zhuo Z; Wang Y; Yang S; Chen J; Wang Y; Geng S; Li M; Du X; Lai P; Weng J
    Front Cell Dev Biol; 2021; 9():800267. PubMed ID: 35127715
    [No Abstract]   [Full Text] [Related]  

  • 7. Prognosis and Characterization of Immune Microenvironment in Acute Myeloid Leukemia Through Identification of an Autophagy-Related Signature.
    Fu D; Zhang B; Wu S; Zhang Y; Xie J; Ning W; Jiang H
    Front Immunol; 2021; 12():695865. PubMed ID: 34135913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of TPD52 in acute myeloid leukemia: A retrospective multicohort analysis.
    Ha M; Han ME; Kim JY; Jeong DC; Oh SO; Kim YH
    J Cell Biochem; 2019 Mar; 120(3):3672-3678. PubMed ID: 30203488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integration of CD34
    Li XP; Zhang WN; Mao JY; Zhao BT; Jiang L; Gao Y
    J Transl Med; 2022 Aug; 20(1):359. PubMed ID: 35962395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of a siglec-based and aging-related 9-gene signature for predicting prognosis in acute myeloid leukemia patients.
    Shi H; Gao L; Zhang W; Jiang M
    BMC Bioinformatics; 2022 Jul; 23(1):284. PubMed ID: 35854240
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Analysis of Autophagy-Related Signature Uncovers Prognostic Predictor for Acute Myeloid Leukemia.
    Chen XX; Li ZP; Zhu JH; Xia HT; Zhou H
    DNA Cell Biol; 2020 Sep; 39(9):1595-1605. PubMed ID: 32783661
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    Bai H; Zhou M; Zeng M; Han L
    DNA Cell Biol; 2020 Apr; 39(4):700-708. PubMed ID: 32077754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High NCALD expression predicts poor prognosis of cytogenetic normal acute myeloid leukemia.
    Song Y; Zhang W; He X; Liu X; Yang P; Wang J; Hu K; Liu W; Zhang X; Jing H; Yuan X
    J Transl Med; 2019 May; 17(1):166. PubMed ID: 31109331
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Construction and Validation of a Novel Ferroptosis-Related Prognostic Model for Acute Myeloid Leukemia.
    Song Y; Tian S; Zhang P; Zhang N; Shen Y; Deng J
    Front Genet; 2021; 12():708699. PubMed ID: 35111195
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic value of an eighteen-genes panel in acute myeloid leukemia by analyzing TARGET and TCGA databases.
    Chen P; Cao J; Chen L; Gao G; Xu Y; Jia P; Li Y; Li Y; Du J; Zhang S; Zhang J
    Cancer Biomark; 2023; 36(4):287-298. PubMed ID: 36938728
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive Analysis of Prognostic Markers for Acute Myeloid Leukemia Based on Four Metabolic Genes.
    Zhang Y; Ma S; Wang M; Shi W; Hu Y
    Front Oncol; 2020; 10():578933. PubMed ID: 33117716
    [No Abstract]   [Full Text] [Related]  

  • 17. Higher Expression of
    Chen C; Chen Z; Chio CL; Zhao Y; Li Y; Liu Z; Jin Z; Wu X; Wei W; Zhao Q; Li Y
    Technol Cancer Res Treat; 2021; 20():15330338211052152. PubMed ID: 34738847
    [No Abstract]   [Full Text] [Related]  

  • 18. [Prognostic implications and functional enrichment analysis of LTB4R in patients with acute myeloid leukemia].
    Zhang X; Zhang X; Liu P; Liu K; Li W; Chen Q; Ma W
    Nan Fang Yi Ke Da Xue Xue Bao; 2022 Mar; 42(3):309-320. PubMed ID: 35426793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
    Wu P; Zheng Y; Wang Y; Wang Y; Liang N
    J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High expression of CD56 may be associated with favorable overall survival in intermediate-risk acute myeloid leukemia.
    Chen C; Chio CL; Zeng H; Li Y
    Hematology; 2021 Dec; 26(1):210-214. PubMed ID: 33594945
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.